Shannon L. Devers sold $3.8M of Ionis Pharmaceuticals (IONS)

Executed Jan 7, disclosed Jan 9, 2 days later.

Value, as filed

$3.8M

44,199 sh across 5 lots

Executed

Jan 7

the trade date, as filed

Disclosed

Jan 9

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SD Shannon L. Devers EVP, Chief Human Resources Ofc profile →

Shannon L. Devers (EVP, Chief Human Resources Ofc) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $3.8M of IONS (44,199 sh across 5 lots, as filed), executed Jan 7.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Shannon L. Devers in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $459K
6,193 sh × $74.05
Exec Apr 2
Filed Apr 2 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $1.5M
19,351 sh across 2 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $323K
3,977 sh × $81.34
Exec Jan 22
Filed Jan 23 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $634K
8,353 sh × $75.95
Exec Jan 16
Filed Jan 20 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $1.4M
16,777 sh × $80.91
Exec Nov 25 2025
Filed Nov 28 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $438K
6,000 sh × $72.94
Exec Oct 15 2025
Filed Oct 16 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $193K
3,162 sh × $61.02
Exec Sep 3 2025
Filed Sep 4 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $140K
4,267 sh × $32.78
Exec Jan 16 2025
Filed Jan 17 2025 · 5:30 PM ET